How does informed consent for research differ from standard clinical consent in HIM contexts?

• A. Research consent covers use of PHI for research; may be waived under IRB; includes additional privacy protections and may not align with routine clinical consent.
• B. Research consent is identical to clinical consent.
• C. Research consent not required if data is de-identified.
• D. Research consent covers only payment and billing.

Answer: (A)

In HIM, the important distinction is the purpose and scope of consent. For research, consent (often called authorization) specifically addresses permission to use identifiable health information for research purposes. This authorization is separate from consent to receive clinical care and may include additional privacy protections tailored to research. Importantly, an IRB can waive this authorization under certain criteria, allowing researchers to use PHI without patient authorization when safeguards are in place and the research meets minimal risk standards. This combination of PHI use for research, possible IRB waivers, and heightened privacy protections means research consent can differ markedly from routine clinical consent, which is focused on treatment decisions and disclosures related to care rather than research activities. In clinical care, there isn’t usually a blanket authorization for researchers to access PHI, and the privacy safeguards are governed by general patient-physician disclosures rather than the study-specific protections found in research contexts.